Agenus Inc. (NASDAQ:AGEN – Get Rating)’s stock price gapped up prior to trading on Friday . The stock had previously closed at $1.41, but opened at $1.45. Agenus shares last traded at $1.44, with a volume of 1,865,562 shares trading hands. Analysts Set New Price Targets Several research firms have recently weighed in on AGEN. […]
StockNews.com began coverage on shares of Agenus (NASDAQ:AGEN – Get Rating) in a research report released on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock. A number of other analysts have also commented on AGEN. HC Wainwright reissued a buy rating and issued a $8.00 target price on shares of Agenus […]
Agenus Inc. (NASDAQ:AGEN – Get Rating) major shareholder Agenus Inc purchased 22,065 shares of the stock in a transaction on Wednesday, May 10th. The stock was acquired at an average price of $1.51 per share, with a total value of $33,318.15. Following the acquisition, the insider now directly owns 21,617,112 shares in the company, valued […]
Agenus Inc. (NASDAQ:AGEN – Get Rating) was the recipient of a large decline in short interest in April. As of April 30th, there was short interest totalling 19,550,000 shares, a decline of 18.1% from the April 15th total of 23,880,000 shares. Based on an average daily volume of 5,150,000 shares, the short-interest ratio is presently […]
Agenus Inc. (NASDAQ:AGEN – Get Rating) – Research analysts at B. Riley raised their Q2 2023 earnings per share estimates for shares of Agenus in a research note issued to investors on Wednesday, May 10th. B. Riley analyst M. Mamtani now anticipates that the biotechnology company will post earnings per share of ($0.18) for the […]